Clinical trials about the correlation of change and PSA of the MRI (DWI-ADC) after a treatment halfway point and the end of treatment radiotherapy for prostate cancer

Clinical trials about the correlation of change and PSA of the MRI (DWI-ADC) after a treatment halfway point and the end of treatment radiotherapy for prostate cancer - Correlation of change and PSA of the MRI after a treatment halfway point and the end of treatment radiotherapy for prostate cancer

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000022636

Enrollment

Registered

2016-06-07

Start date

2016-06-07

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

prostate cancer

Interventions

None listed

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: Performance status is the patient of 0 or 1. The patients that a written consent was obtained.

Exclusion criteria

Exclusion criteria: Patient with no informed consent.

Design outcomes

Primary

Measure	Time frame
A correlation is seen in MRI image findings and a value of the blood test PSA	—

Countries

Japan

Contacts

Public ContactOSAMU TANAKA

Gifu Municipal Hospital Department of Radiation Oncology

c.bluered@gmail.com+819076730893

Outcome results